Pre-Operative Chemotherapy Followed by Surgery for N2 Non-Small Cell Lung Cancer: A 15-Year Experience

被引：0
|
作者：
Spicer, Jonathan D. [1 ]
Shewale, Jitesh [1 ]
Correa, Arlene M. [1 ]
Heymach, John V. [2 ]
Antonoff, Mara B. [1 ]
Hofstetter, Wayne [1 ]
Mehran, Reza [1 ]
Roth, Jack [1 ]
Rice, David [1 ]
Sepesi, Boris [1 ]
Vaporciyan, Ara A. [1 ]
William, William [2 ]
Walsh, Garrett [1 ]
Swisher, Stephen [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Thorac & Cardiovasc Surg, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
lung cancer; Surgery; chemotherapy; N2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03-017
引用
收藏
页码：S571 / S572
页数：2
相关论文
共 50 条
  • [31] Prognostic Factors in Pathologic N2 Non-Small Cell Lung Cancer
    Kim, Hye-Seon
    Cho, Sukki
    Kim, Kwhanmien
    Jheon, Sanghoon
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S578 - S578
  • [32] Surgical Resection of Non-Small Cell Lung Cancer with N2 Disease
    Donington, Jessica S.
    Pass, Harvey I.
    THORACIC SURGERY CLINICS, 2014, 24 (04) : 449 - +
  • [33] Management of Stage IIIA (N2) Non-Small Cell Lung Cancer
    Gillaspie, Erin A.
    Wigle, Dennis A.
    THORACIC SURGERY CLINICS, 2016, 26 (03) : 271 - +
  • [34] N2 institutional consensus on Non-Small Cell Lung Cancer (NSCLC)
    Eid, H.
    El Kik, A.
    Karam, E.
    Chamaa, A.
    Habr, B.
    El Karak, F.
    Kourie, H.
    Azouri, F.
    Smayra, V.
    Aoun, N.
    Kattan, J.
    Chahine, G.
    Ghosn, M.
    Wakim, J.
    Nasserddine, H.
    Nasr, F.
    Khayat, G.
    Nakad, J.
    Harmouche, C.
    Dabar, G.
    Tabet, G.
    Aoun, Z.
    Riachy, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] PROGNOSIS OF SKIP N2 NON-SMALL CELL LUNG CANCER (NSCLC)
    Chang, Y.
    Cho, D.
    Choi, S.
    CHEST, 2020, 157 (06) : 23A - 23A
  • [36] TREATMENT OF N2 NON-SMALL CELL LUNG-CANCER (NSCLC)
    KLASTERSKY, J
    FELD, R
    KLEISBAUER, JP
    ROCMANS, P
    CHEST, 1989, 96 (01) : S83 - S85
  • [37] Clinical predictors of N2 disease in non-small cell lung cancer
    Takamochi, K
    Nagai, K
    Suzuki, K
    Yoshida, J
    Ohde, Y
    Nishiwaki, Y
    CHEST, 2000, 117 (06) : 1577 - 1582
  • [38] Chemotherapy Followed by Surgery on the Basis of Biomarker Examination for Patients with Advanced Non-small Cell Lung Cancer
    Yokomise, Hiroyasu
    Liu, Dage
    Ishikawa, Shinya
    Go, Tetsuhiko
    Gotoh, Masashi
    Okuda, Masaya
    Tarumi, Shintaroh
    Kasai, Yoshitaka
    Matsuura, Natsumi
    ANTICANCER RESEARCH, 2013, 33 (12) : 5597 - 5602
  • [39] Pre-operative histological classification of primary lung cancer: Accuracy of diagnosis and use of the "non-small cell" category
    Edwards, SL
    Roberts, C
    McKean, ME
    Cockburn, JS
    Jeffrey, RR
    Kerr, KM
    JOURNAL OF PATHOLOGY, 1999, 189 : 25A - 25A
  • [40] Locally advanced non-small cell lung cancer:: role of induction chemotherapy in resectable N2 disease
    Migliorino, MR
    De Petris, L
    De Santis, S
    Cipri, A
    Belli, R
    Condò, S
    Ariganello, O
    Di Molfetta, M
    Saponiero, A
    de Marinis, F
    ANNALS OF ONCOLOGY, 2006, 17 : 28 - 31
12345